Harm reduction policies for tobacco users

The International Journal on Drug Policy
Coral E Gartner, Wayne D Hall

Abstract

Tobacco harm reduction is a controversial policy due to the experience with filtered and 'light' cigarettes and concerns that the tobacco industry will use reduced harm products to undermine tobacco control strategies. The most promising harm reduction products are high dose pharmaceutical nicotine preparations and low nitrosamine smokeless tobacco, such as Swedish snus. However, despite widespread availability, existing pharmaceutical nicotine preparations have not been taken up by smokers as an alternative to smoking. In Sweden, increased snus use was associated with decreased cigarette smoking and mortality from tobacco-related disease. We suggest a graduated series of policies to explore of the public health costs and benefits of encouraging smokers to switch to these less harmful nicotine products.

References

Oct 7, 1997·JAMA : the Journal of the American Medical Association·K E WarnerD T Sweanor
Dec 9, 2003·Tobacco Control·J FouldsK Fagerström
May 22, 2004·Nature Reviews. Genetics·UNKNOWN International HapMap Consortium
Sep 30, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Mark Parascandola
May 27, 2006·Tobacco Control·L M Ramström, J Foulds
Jul 10, 2007·Journal of the American College of Surgeons·UNKNOWN American College Of Radiology
Mar 25, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·David S TimberlakeCynthia M Lakon
Aug 19, 2009·Addiction·Coral Gartner, Wayne Hall

❮ Previous
Next ❯

Citations

Jan 12, 2011·Harm Reduction Journal·Richard J O'ConnorRon Borland
Aug 15, 2013·American Journal of Health Promotion : AJHP·Laura Romito, M Kim Saxton
May 25, 2012·Drug and Alcohol Dependence·Mehmet Sofuoglu, Mark G LeSage
Feb 23, 2010·The International Journal on Drug Policy·Gerry V Stimson, Pat O'Hare
Dec 3, 2013·Addictive Behaviors·Karl Olov Fagerström, Kevin Bridgman
Apr 26, 2011·Drug and Alcohol Dependence·Dorothy K HatsukamiHerb Severson
Feb 27, 2014·Tobacco Control·Lois BienerLaura Romito
Jan 14, 2016·Tobacco Control·Ratika SharmaCoral E Gartner
Oct 24, 2017·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Gerhard GmelJoseph Studer
Feb 16, 2017·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Vikrant R MohantyVipul Yadav
Oct 12, 2017·Journal of American College Health : J of ACH·Kimberly G WagonerMark Wolfson
Apr 7, 2021·Addiction·Pauline J Ford, Alison M Rich
Aug 30, 2011·Pediatrics·Anna GunnerbeckSven Cnattingius

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.